Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medimorphic was the trade name/brand associated with C-Beyond Health, a private cannabinoid-focused healthcare and product development company based in Golden, Colorado. The company developed medicinal cannabis-based consumer products and described its business as combining pharmaceutical-industry precision with cultivation, extraction, formulation, manufacturing, and branding capabilities. Its public materials emphasized direct-to-consumer cannabinoid blended products, targeted cannabinoid formulations, and a vertically integrated "seed-to-body" platform, including genetics, cultivation, formulation, and manufacturing. Medimorphic also promoted consumer brands such as nuhumun and pursued operations in both the United States and Thailand. Available business-directory and company-profile sources indicate the company is now closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medimorphic.